ArticleBioMed research international2025
Phenolic Compounds of
Article in BioMed research international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fractional Factorial Design-Guided Optimization of Flavonoid Content and Antioxidant Capacity inPharmaceuticals (Basel, Switzerland) · 2026Article
- Phenolic Compounds ofBioMed research international · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: The plant sample was collected, dried, and grinded into coarse powder which was then soaked in methanol for 2 weeks. After the maceration process, the crude methanolic extract was subjected to solvent-solvent partitioning into four different fractions: n-hexane soluble fraction (HSF), dichloromethane soluble fraction (DMSF), ethyl acetate soluble fraction (EASF), and aqueous fraction (AQF). DMSF was chemically evaluated through chromatographic separation, and all the fractions including the crude methanolic extracts were assessed for their potential pharmacological activities against pain, oxidative stress, hyperglycemia, diarrhea, and microbes following standard protocols. Results: Chemical investigation results in the isolation of lupeol, Conclusion: Three isolated phytochemicals demonstrate promising binding affinities with the receptor molecules that support the pharmacological findings of this study. However, additional research needs to be conducted to isolate more phytoconstituents and affirm the pharmacological potential of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.